麻醉疼痛

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛

病例讨论：老年心衰患者PFNA内固定术的麻醉管理

2022-04-27 醉美玉兰 醉美玉兰

心衰麻醉管理
关注

收藏学习～

心衰是由心脏结构/功能异常引起相应症状/体征的一种综合征，患病率随着年龄的增长而增加：<55岁的患病率约1%>10%；根据EF值分将心衰分为三种类型:为HFrEF(EF≤40%)、HFmEF(41%≤EF≤49%)、HFpEF(EF≥50%) ，本次病例为大家分享了老年心衰患者PFNA术中关注要点及心衰的部分解读 。图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2023-04-01 4720230 来自重庆

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2023-04-01 4720230 来自重庆

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-09-15 yxch36

    #病例讨论#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2023-03-15 passed water

    #FNA#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-06-09 1404030bm81暂无昵称

    写的很好。知识更新的好多。谢谢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-04-29 yuanming7

    #心衰患者#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2123167, encodeId=bf9c212316ebb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:27:26 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2123166, encodeId=f7cd21231664a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30523000173, createdName=4720230, createdTime=Sat Apr 01 19:26:44 CST 2023, time=2023-04-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1986308, encodeId=a5f119863084c, content=<a href='/topic/show?id=7454e07856a' target=_blank style='color:#2F92EE;'>#病例讨论#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70785, encryptionId=7454e07856a, topicName=病例讨论)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Sep 15 15:44:50 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021972, encodeId=edbc20219e26b, content=<a href='/topic/show?id=e9e6e55483' target=_blank style='color:#2F92EE;'>#FNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7554, encryptionId=e9e6e55483, topicName=FNA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Wed Mar 15 20:44:50 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225422, encodeId=764712254220b, content=写的很好。知识更新的好多。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bab14366036, createdName=1404030bm81暂无昵称, createdTime=Thu Jun 09 12:45:09 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373565, encodeId=e17b13e35654c, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546720, encodeId=4cca1546e2089, content=<a href='/topic/show?id=2230303e266' target=_blank style='color:#2F92EE;'>#内固定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30372, encryptionId=2230303e266, topicName=内固定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4faa13929419, createdName=41514491@qq.com, createdTime=Fri Apr 29 06:44:50 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-04-29 41514491@qq.com

    #内固定#

    0

相关资讯

JACC：震惊，经历过不孕的女性患心力衰竭的风险增加16%！

妇女不孕不育与发生的HF显著相关。

ACC/AHA/HFSA 2022：推荐SGLT-2抑制剂用于治疗心衰

无论糖尿病状况如何，DAPA-HF 和 EMPEROR-HF 试验都证明用 SGLT-2 抑制剂治疗 HFrEF 患者的益处，显示心力衰竭再住院率降低了 30%。

Ann Intern Med：心衰患者钠-葡萄糖共转运蛋白2抑制剂的效果分析

随机对照试验确定了钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂对2型糖尿病患者具有心脏保护作用。新的证据表明，这些结果可以扩展到没有糖尿病的个体。

JAHA：抑郁症状与心衰住院事件

在基线时无CHD的个体中，抑郁症状与HFpEF事件住院有关，但与HFrEF或基线CHD无关。

JAHA：中枢性呼吸暂停对女性心衰患者危害更大

在慢性HF患者中，中枢性呼吸暂停与女性相比男性发生不良事件的风险更高。

ACC | 心衰患者接受营养风险筛查，可减少不良心血管事件

尽早进行营养干预，很有必要！